Scientists in Laboratory

Developed Under a National Institute on Drug Abuse (NIDA) Contract

Deterra’s Drug Deactivation Technology Destroys Drugs for Good

Two Deterra Pouches

The patented Deterra® Drug Deactivation System was developed under two Small Business Innovation Research contracts from the National Institute on Drug Abuse (NIDA), a division of the National Institutes of Health (NIH). Titled “In-home Deactivation System for Psychoactive Drugs,” the award information may be found here:

During development, the proprietary activated carbon that powers Deterra System was rigorously tested by independent, third-party researchers at Mercer University’s College of Pharmacy. Testing shows Deterra’s activated carbon is highly effective at firmly binding to the active ingredients in prescription and over the counter medications, rendering them inert, unavailable for misuse and safe for disposal in the normal trash.

SCIENTIFIC RESEARCH STUDIES

Created by Verde Environmental Technologies, Inc., Deterra System’s proprietary activated carbon technology has been independently lab-tested and proven to permanently and irreversibly deactivate unwanted medications, including over-the-counter medications and dangerous narcotics like opioids and benzodiazepines. Click on a study and select ‘Read Now’ to view a full report.

National Institute on Drug Abuse Logo

NIDA Study: In-Home Deactivation System for Psychoactive Drugs

Research conducted under the National Institute on Drug Abuse (NIDA) contract found the activated carbon in Deterra to be highly effective in adsorbing and deactivating pharmaceuticals. The research also found that 95% of consumers had no difficulty using the Deterra Pouch, with 96% of respondents using the Deterra Pouch within 4 weeks of receiving it.

Peer-Reviewed Publications

Nature Logo

Nature (2020)

Research published in Nature shows that Deterra deactivated 99% of the drugs tested.

Taylor & Francis Logo

Drug Development and Industrial Pharmacy (2018)

A study published in Drug Development and Industrial Pharmacy found an average of 98.72% of medications were adsorbed by activated carbon within 8 hours and continued to do so over time. At the end of the 28-day study, more than 99.99% of all drugs were deactivated.

ScienceDirect Logo

Journal of Pharmaceutical Analysis (2018)

Research published in the Journal of Pharmaceutical Analysis examined the deactivation efficiency of the Deterra System and found more than 99% drug deactivation achieved after 24 hours.

NCBI Logo

Pharmaceutics (2016)

A study published in Pharmaceutics tested the deactivation efficiency of Deterra System with three model psychoactive drugs. By the end of 28 days, over 99% of all drugs were deactivated.

NCBI Logo

Pharmaceutical Research (2016)

A study published in Pharmaceutical Research found that deactivation systems containing activated carbon are promising for efficient, safe and environment friendly disposal of unused and expired medications.

Taylor & Francis Logo

Drug Development and Industrial Pharmacy (2018)

A study published in Drug Development and Industrial Pharmacy found an average of 98.72% of medications were adsorbed by activated carbon within 8 hours and continued to do so over time. At the end of the 28-day study, more than 99.99% of all drugs were deactivated.

Mercer University Logo

Peer-Reviewed American Association of Pharmaceutical Scientists (AAPS) Posters

Mercer University researchers conducted third-party testing of the Deterra System to evaluate the effectiveness of activated carbon in deactivating pills, capsules, patches, liquids, creams and films. Their results are shown in the below poster presentations prepared for the American Association of Pharmaceutical Scientists (AAPS).

Evaluation of an Activated Carbon-based Drug Disposal System for Deactivation of Psychoactive Medications

Researchers found that activated carbon rapidly deactivated ketamine, quetiapine, tramadol and zolpidem.

Deactivation of Psychoactive Drugs Using an Activated Carbon-based Drug Disposal System

This study demonstrated Deterra successfully deactivated alprazolam, dextroamphetamine, lorazepam and temazepam.

Activated Carbon-based Disposal of Fentanyl Transdermal Patches

Researchers found the Deterra Pouch successfully deactivated fentanyl and did not release the adsorbed drug upon attempts at extraction.

Development and Validation of a Reverse Phase-HPLC Method for Methylphenidate and its Disposal using Activated Charcoal-based System

Researchers tested the efficiency of the Deterra Drug Deactivation System and found it successfully deactivated methylphenidate.

Activated Carbon-based Disposal of Model Psychoactive Medications

Researchers examined Deterra’s ability to deactivate buprenorphine, diazepam, fluoxetine, morphine and oxycodone. They concluded Deterra successfully deactivated adsorbed these medications and the drugs could not be extracted from the carbon.

Comparison of Adsorbents for Development of Disposal Kits for Solid Oral Dosage Forms

This study demonstrated activated carbon to be significantly more effective in deactivating amoxicillin and dexamethasone as compared to cat litter or coffee grounds.

Development of a Disposal System for Deactivation of Transdermal Patches of Fentanyl

Researchers found activated carbon was effective in deactivating more than 90% of the fentanyl content of transdermal patches.

Additional Publications

Additional research conducted with Deterra Drug Disposal System is available below.

Deterra Drug Deactivation System Logo

Deterra® System Deactivation of Unused Drugs: Comparison Between Deterra Ingredients and Others Recommended in Federal and SmartRx Disposal Guidelines

This study examines Deterra’s ability to deactivate several model drugs and compares the results to those obtained by utilizing ingredients recommended in federal guidelines. On average, Deterra performed more than four times better than the other adsorbents in deactivating amoxicillin, dexamethasone, diphenhydramine, Effexor XR, ibuprofen, ketoprofen, naproxen, generic Percocet and generic Vicodin.

Deterra Drug Deactivation System Logo

Deterra with TCLP Extraction Solution

This study demonstrated the ability of Deterra’s proprietary carbon to retain adsorbed drugs under simulated landfill conditions by using the sample pre-treatment recommendations and the acidic extraction solution designated in the Environmental Protection Agency’s “Toxicity Characteristic Leaching Procedure.”

It’s Not Destroyed if It’s Not Deterra

  • Our technology is protected by 11 U.S. patents and 33 international patents and cannot be replicated by others.
  • Developed under a federal contract with the National Institute on Drug Abuse (NIDA), Deterra has been independently tested and proven to deactivate drugs.
  • We don’t just mask medications in a gel or liquid; our patented approach completely destroys pills, patches, liquids, creams and films.
  • Deterra is the only carbon-based product that contains sufficient activated carbon to deactivate the amount of medication per label claims.
Medications Icon
0 600

million medications deactivated so far

Patent Icon
0 11

U.S. patents, 33 international patents and 3 U.S. patents pending

Locations Icon
0 50

available in all 50 states and internationally

Deterra is Endorsed by CADCA & the DEA Educational Foundation

Deterra System is endorsed by the DEA Educational Foundation and Community Anti-Drug Coalitions of America (CADCA) for unused drug deactivation and disposal. ​Deterra is the only product that CADCA has endorsed in its 30-year history. Both organizations cite Deterra’s strong scientific backing and proven effectiveness as reasons why Deterra products are trusted over other products on the market.

 

Deterra LogoDisposeRX logoNarcX logoRXDestroyer logoDrugBuster logo
Permanently Destroy Drugs¹
Patented²
Developed under Federal Contract
with the National Institute of Drug Abuse (NIDA)
Prevents future environmental contamination³
Uses environmentally sound plant-based packaging⁴
Deterra LogoDisposeRX logoNarcX logoRXDestroyer logoDrugBuster logo
Permanently Destroy Drugs¹
Patented²
Developed under Federal Contract
with the National Institute of Drug Abuse (NIDA)
Prevents future environmental contamination³
Uses environmentally sound plant-based packaging⁴

¹ When used as directed according to label instructions.
² Deterra has 11 U.S. patents and 23 International patents which include using activated carbon in a sealable container for deactivating and preventing later indecent extraction of medications.
³ Future environmental contamination based on the likelihood of extractable active medications still available when used according to the label instructions.
As a percentage compared to Deterra products, competitor products contain an increased percentage of plastic when disposed: DisposeRx® 59%; NarcX® 78%; RX Destroyer™ 68%; Drug Buster® 67%.

DESTROY DRUGS – NOT THE ENVIRONMENT

Improper disposal of unused and expired medications damages our environment. Deterra System is environmentally sound through the entire product life cycle. Deterra’s innovative plant-based pouch is produced using 100% wind-generated power and it contains non-toxic ingredients. Made from environmentally sound materials, Deterra is safer for the environment because our proprietary, organic activated carbon prevents harmful medications from contaminating landfills and water systems.¹ Additionally, Deterra Pouches contain a smaller percentage of plastic when disposed of than competitor products.²

 

¹ Based on the likelihood of extractable active medications available when used according to label instructions.
² Compared to Deterra products, competitor products contain a higher percentage of plastic when disposed of: DisposeRx® 59%; NarcX® 78%; Rx Destroyer™ 68%; Drug Buster® 67%

Variety of Deterra Products

Deterra Drug Deactivation System

The Deterra System is the only solution for safe, permanent medication disposal. The simple, three-step process permanently deactivates ingredients and renders medications inert so they can’t be accidentally ingested, stolen, abused or leeched into our ecosystem. Deterra’s patented products are simple, safe and can be used at home or in a clinical setting.